• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Oncology

Girls with familial breast cancer history are well-adjusted

byMikhaela MontyandCordelia Ross
October 19, 2015
in Oncology, Pediatrics, Psychiatry
Reading Time: 2 mins read
Girls with familial breast cancer history are well-adjusted
Share on FacebookShare on TwitterShare on LinkedIn

1. Daughters of mothers with a family history of breast cancer or familial BRCA1/2 mutation (BCFH+) had better psychosocial adjustment than BCFH- controls.

2. BCFH+ girls had higher levels of breast cancer-specific distress and believed they had a higher risk for breast cancer than their peers, as compared to BCFH- controls.

Evidence Rating Level: 2 (Good) 

Study Rundown: Breast cancer is the second most commonly diagnosed cancer among women in the United States. In recent years, genetic testing of familial breast cancer mutations has become more commonplace. Understanding the psychosocial impact of familial cancer history has implications on how and when information and testing options should be shared with children. This study is the first to explore the psychosocial impact of familial breast cancer in mothers and their pre-adolescent daughters, a time during which many healthy behavior patterns are entrenched. Results indicated that BCFH+ girls had better psychosocial adjustment and health behaviors than BCFH- girls. However, BCFH+ girls reported significantly greater breast cancer-specific distress, and they believed that they had higher breast cancer risk than their peers. In addition, higher levels of stress among BCFH+ girls were associated with increased levels of maternal anxiety and more limited family communication. While this study highlights avenues that can be addressed to improve psychosocial outcomes of girls with familial breast cancer history, it is limited by the selection of mother-daughter pairs as subjects.

Click to read the study, published today in Pediatrics

Relevant Reading: Management of an inherited predisposition to breast cancer

RELATED REPORTS

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

In-Depth [survey]: Participants included 869 girls ages 6 to 13 years (mean age 9.5 years), and their mothers, from 4 major US cities (New York City, Philadelphia, Salt Lake City, San Francisco) and Ontario, Canada between August 2011 and July 2013. The girls were from families with and without breast cancer in first or second-degree relatives or BRCA1/2 mutations. Both mothers and daughters ages 10-13 completed surveys, while mothers of younger girls were asked to answer on their behalf. Among all age groups, BCFH+ daughters had lower internalizing problems compared with BCFH- daughters (13% vs 15%, P=.02). Mothers in the BCFH+ group had higher general anxiety and breast cancer-specific distress compared to BCFH- mothers (7.1 vs 6.4, P=0.18 and 7.6 vs 3.2, P < .001 respectively). Similarly, BCFH+ girls experienced higher levels of breast cancer-related distress compared to BCFH- girls (12% vs 5%, P=.02). BCFH+ daughters were 2.8 times more likely to consider themselves at increased risk for breast cancer compared to their peers (95%CI 1.9-4.2). Furthermore, higher levels of BCFH+ daughter anxiety was associated with higher levels of maternal anxiety (P < .001) and poorer family communication (P=.02).

Image: CC

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Breast Cancerbreast cancer survival
Previous Post

First stage of labor models show promise in predicting complications

Next Post

Gestational and post-delivery weight gain linked to overweight children

RelatedReports

Oncology

Giredestrant plus everolimus improves progression-free survival in treatment-resistant breast cancer

October 5, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Chronic Disease

Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy

September 3, 2026
Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ
Chronic Disease

Tumour microenvironment factors may influence cancer progression and response to tamoxifen (Nolvadex) in patients with estrogen receptor-positive and human epidermal growth factor receptor 2 breast cancer

August 13, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Next Post
Late gestation antidepressant use linked to postpartum hemorrhage

Gestational and post-delivery weight gain linked to overweight children

AAP recommends disaster preparedness measures for children

AAP recommends disaster preparedness measures for children

Gastric bypass surgery reduces cardio-metabolic risk factors

2 Minute Medicine Rewind October 12 – 18, 2015

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Artificial intelligence (AI)-powered mental health app demonstrated improved social well-being among users
  • Children with intellectual and developmental disabilities have increased risks of depression and anxiety
  • Gabapentin (Neurontin) prescription for chronic low back pain in adults is associated with a higher risk of dementia
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.